Shares of VirnetX Holding Corp (NYSE:VHC - Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $11.45 and traded as high as $17.50. VirnetX shares last traded at $17.05, with a volume of 2,754 shares traded.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen upgraded shares of VirnetX from a "sell" rating to a "hold" rating in a research note on Saturday, August 16th.
Check Out Our Latest Report on VirnetX
VirnetX Stock Up 6.4%
The stock's 50-day moving average is $16.23 and its 200-day moving average is $11.45. The firm has a market cap of $72.78 million, a P/E ratio of -3.55 and a beta of 1.74.
VirnetX (NYSE:VHC - Get Free Report) last announced its earnings results on Tuesday, August 12th. The technology company reported ($0.99) earnings per share (EPS) for the quarter. The company had revenue of $0.05 million for the quarter.
Hedge Funds Weigh In On VirnetX
An institutional investor recently raised its position in VirnetX stock. Csenge Advisory Group raised its holdings in VirnetX Holding Corp (NYSE:VHC - Free Report) by 11.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,002 shares of the technology company's stock after buying an additional 2,448 shares during the quarter. Csenge Advisory Group owned 0.57% of VirnetX worth $177,000 as of its most recent SEC filing. 10.37% of the stock is owned by hedge funds and other institutional investors.
VirnetX Company Profile
(
Get Free Report)
VirnetX Holding Corporation, through its subsidiary VirnetX, Inc, operates as an Internet security software and technology company primarily in the United States. The company develops software and technology solutions, including secure domain name registry and GABRIEL Connection Technology that are designed to secure communications over the Internet using zero trust network access.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider VirnetX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VirnetX wasn't on the list.
While VirnetX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.